MD3710446T2 - Compuși utili pentru inhibarea CDK7 - Google Patents

Compuși utili pentru inhibarea CDK7

Info

Publication number
MD3710446T2
MD3710446T2 MDE20200963T MDE20200963T MD3710446T2 MD 3710446 T2 MD3710446 T2 MD 3710446T2 MD E20200963 T MDE20200963 T MD E20200963T MD E20200963 T MDE20200963 T MD E20200963T MD 3710446 T2 MD3710446 T2 MD 3710446T2
Authority
MD
Moldova
Prior art keywords
compounds useful
inhibiting cdk7
cdk7
inhibiting
pharmaceutically acceptable
Prior art date
Application number
MDE20200963T
Other languages
English (en)
Inventor
David Andrew Coates
Carlos Montero
Bharvin Kumar Rameschandra Patel
David Michael Remick
Vipin Yadav
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MD3710446T2 publication Critical patent/MD3710446T2/ro

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Abstract

Prezenta invenţie furnizează noi inhibitori CDK7 şi compoziţii farmaceutice ale acestora:sau o sare acceptabilă farmaceutic a acestora.
MDE20200963T 2017-11-16 2018-11-09 Compuși utili pentru inhibarea CDK7 MD3710446T2 (ro)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17382778 2017-11-16
EP18382034 2018-01-23
EP18382546 2018-07-20
PCT/US2018/060025 WO2019099298A1 (en) 2017-11-16 2018-11-09 Compounds useful for inhibiting cdk7

Publications (1)

Publication Number Publication Date
MD3710446T2 true MD3710446T2 (ro) 2022-12-31

Family

ID=64477309

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20200963T MD3710446T2 (ro) 2017-11-16 2018-11-09 Compuși utili pentru inhibarea CDK7

Country Status (31)

Country Link
US (3) US10472370B2 (ro)
EP (1) EP3710446B1 (ro)
JP (1) JP6633254B2 (ro)
KR (1) KR102450727B1 (ro)
CN (1) CN111344292B (ro)
AU (1) AU2018369508B2 (ro)
BR (1) BR112020008253A2 (ro)
CA (1) CA3080910C (ro)
CL (1) CL2020001218A1 (ro)
CR (1) CR20200184A (ro)
DK (1) DK3710446T3 (ro)
DO (1) DOP2020000102A (ro)
EC (1) ECSP20025899A (ro)
ES (1) ES2925219T3 (ro)
HR (1) HRP20221152T1 (ro)
HU (1) HUE060078T2 (ro)
IL (1) IL274540B (ro)
JO (1) JOP20200122B1 (ro)
LT (1) LT3710446T (ro)
MD (1) MD3710446T2 (ro)
MX (1) MX2020004932A (ro)
MY (1) MY197700A (ro)
NZ (1) NZ763551A (ro)
PE (1) PE20210392A1 (ro)
PL (1) PL3710446T3 (ro)
RS (1) RS63530B1 (ro)
SA (1) SA520411990B1 (ro)
SG (1) SG11202003677UA (ro)
SI (1) SI3710446T1 (ro)
TW (1) TWI703149B (ro)
WO (1) WO2019099298A1 (ro)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3805218A1 (en) * 2014-04-05 2021-04-14 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
TWI703149B (zh) * 2017-11-16 2020-09-01 美商美國禮來大藥廠 用於抑制cdk7之化合物
IL292519A (en) * 2019-10-29 2022-06-01 Syros Pharmaceuticals Inc Methods for treating cancer in patients identified with a biomarker with cyclin-dependent kinase 7 (cdk7) inhibitors
AU2020404326A1 (en) * 2019-12-20 2022-08-11 Evopoint Biosciences Co., Ltd. Heterocyclic compound, and pharmaceutical composition thereof, preparation method therefor, intermediate thereof and application thereof
WO2022033552A1 (zh) * 2020-08-12 2022-02-17 隆泰申医药科技(南京) 有限公司 Cdk激酶抑制剂、其制备方法、药物组合物和应用
USD1004118S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD1004119S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD987844S1 (en) 2021-08-31 2023-05-30 MerchSource, LLC Percussion massager
USD1004117S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD994898S1 (en) 2021-11-17 2023-08-08 MerchSource, LLC Percussion massager
USD995812S1 (en) 2021-11-22 2023-08-15 MerchSource, LLC Percussion massager
USD1018881S1 (en) 2021-12-22 2024-03-19 MerchSource, LLC Percussion massager
USD1009292S1 (en) 2021-12-22 2023-12-26 MerchSource, LLC Percussion massager
USD1004122S1 (en) 2021-12-31 2023-11-07 MerchSource, LLC Pivoting percussion massager
USD1004121S1 (en) 2021-12-31 2023-11-07 MerchSource, LLC Pivoting percussion massager
CN114452391B (zh) * 2022-01-28 2023-08-25 深圳市泰尔康生物医药科技有限公司 Cdk16作为靶标在制备用于治疗三阴性乳腺癌的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050033659A (ko) * 2002-09-04 2005-04-12 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 피라졸로[1,5-a]피리미딘 화합물
GB201403093D0 (en) 2014-02-21 2014-04-09 Cancer Rec Tech Ltd Therapeutic compounds and their use
EP3805218A1 (en) * 2014-04-05 2021-04-14 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
CA2978170C (en) * 2015-03-09 2024-02-27 Aurigene Discovery Technologies Limited Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
CA2978518C (en) 2015-03-27 2023-11-21 Nathanael S. Gray Inhibitors of cyclin-dependent kinases
MX2017015521A (es) 2015-06-04 2018-11-09 Aurigene Discovery Tech Ltd Derivados de heterociclilos sustituidos como inhibidores de cdk.
EP4019515A1 (en) 2015-09-09 2022-06-29 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
TWI703149B (zh) * 2017-11-16 2020-09-01 美商美國禮來大藥廠 用於抑制cdk7之化合物

Also Published As

Publication number Publication date
PE20210392A1 (es) 2021-03-02
US10472370B2 (en) 2019-11-12
US20210032257A1 (en) 2021-02-04
KR20200070323A (ko) 2020-06-17
US10787460B2 (en) 2020-09-29
JOP20200122A1 (ar) 2020-05-20
US20190144456A1 (en) 2019-05-16
MY197700A (en) 2023-07-06
PL3710446T3 (pl) 2022-10-10
EP3710446A1 (en) 2020-09-23
CN111344292A (zh) 2020-06-26
HRP20221152T1 (hr) 2022-11-25
CA3080910A1 (en) 2019-05-23
CL2020001218A1 (es) 2020-08-21
JOP20200122B1 (ar) 2023-09-17
US20200017513A1 (en) 2020-01-16
ES2925219T3 (es) 2022-10-14
IL274540B (en) 2022-06-01
SG11202003677UA (en) 2020-05-28
DK3710446T3 (da) 2022-08-01
MX2020004932A (es) 2020-08-27
CN111344292B (zh) 2022-06-03
CR20200184A (es) 2020-06-01
AU2018369508B2 (en) 2021-03-11
ECSP20025899A (es) 2020-06-30
IL274540A (en) 2020-06-30
EP3710446B1 (en) 2022-07-20
BR112020008253A2 (pt) 2020-11-17
DOP2020000102A (es) 2020-08-31
RS63530B1 (sr) 2022-09-30
TW201930305A (zh) 2019-08-01
HUE060078T2 (hu) 2023-01-28
NZ763551A (en) 2021-12-24
LT3710446T (lt) 2022-09-26
JP6633254B2 (ja) 2020-01-22
KR102450727B1 (ko) 2022-10-06
CA3080910C (en) 2023-02-07
JP2019537616A (ja) 2019-12-26
TWI703149B (zh) 2020-09-01
WO2019099298A1 (en) 2019-05-23
AU2018369508A1 (en) 2020-05-07
SI3710446T1 (sl) 2022-09-30
SA520411990B1 (ar) 2022-07-24

Similar Documents

Publication Publication Date Title
MD3710446T2 (ro) Compuși utili pentru inhibarea CDK7
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
EA201691421A1 (ru) Гетероарилы и их применение
EA201490161A1 (ru) Соединения - ингибиторы сигналинга, опосредуемого рецептором notch
PH12019501022A1 (en) Pyrazolopyrimidine compounds and methods of use thereof
MD3347360T2 (ro) Compuși utili pentru inhibarea ROR-gama-t
MX2017013875A (es) Ciertos inhibidores de la proteína quinasa.
MX2018014813A (es) Composiciones antibacterianas.
EA202191051A1 (ru) Ингибитор аврора-киназы a для применения для лечения нейробластомы
PH12019500875A1 (en) Pyridone compound as c-met inhibitor
EA201892051A1 (ru) Фармацевтические композиции для лечения злокачественного новообразования
CY1123406T1 (el) Παραγωγο τριαζολοπυραζινονης χρησιμο ως ενας ανθρωπινος pde1 αναστολεας
CY1124258T1 (el) ΕΝΩΣΕΙΣ ΧΡΗΣΙΜΕΣ ΓΙΑ ΑΝΑΣΤΟΛΗ ROR-γ-t
TW201613898A (en) Benzofuran analogue as NS4B inhibitor
CY1124177T1 (el) Ενωσεις χρησιμες για την αναστολη του ror-γαμμα-τ
MX2022001467A (es) Derivados quinolina como inhibidores de proteína quinasa.
MD3707133T2 (ro) Compuși inhibitori de BTK
EA202090930A1 (ru) Соединения, пригодные для ингибирования cdk7
JOP20190159B1 (ar) توليفة من مثبط mcl-1 ومركب تاكسان، استخداماتها وتركيباتها الصيدلانية
UA110834C2 (uk) Сполука-інгібітор сигнального шляху notch